• ABOVE & BEYOND TRADITIONAL EXPECTATIONS

    A HYBRID VENTURES / CAPITAL TEAM

  • THE MISSION

     

    We partner with seasoned founders of cutting edge fast growth companies needing to raise more capital as they are ready to ignite. Our mission is to add an expertise for developing key American businesses in innovative 1 B+ markets, post-seed and evolved startups poised to succeed beyond expectations!

  • A HYBRID PLATFORM

    We have developed a unique go to market collaboration model. We help set it up with preparation and the proper funding ASK. Let us help you get there. We take on your company as long term advisors and partners. We are very selective in the types of investors, founders, team, products and high growth verticals we research to work with. Share your vision with us.

  • PROJECTS

    Q - 4 / 2021

    AGI / Agiculture-tech / Bio-medical / Health-lifestyle / RE Development / Tech

    APOTHEKA 2.5M

    A SaaS platform integrates with Electronic Medical Records Systems (Ex: EPIC, Cerner, Allscripts, etc.) transforms them into secure Blockchain eco-systems. Patent #1 approved #2 Covid use

    LUMOPTIK 2M

    Reflecometer Assisted Medical equipment for performing epidural and other orthopedic surgical procedures requiring accuracy and precision.

    BRIDGE RX 2M

    Non opiod/ non addictive Pharma delivery system designed to combat the current opiod crisis.

    SITE SEE

    AI for communications industry with global reach  

     

    Executive summaries for accredited investors only

     

    Victoria@SteelWolfVentures.com

    SYMSOIL 10M

     
    Robust Compost comprised of microbes blended as probiotic for plant nutrition  as an alternative to agri-chemical fertilizers. IP 

    KINETA

    Biotchnology compsny with a mission to develop next generation Immunotherapies in high unmet needs.

     

    Executive Summaries for

    accredited investors only:

    Victoria@steelwolfventures.com

     

    ARTELUS

    An AI enabled early detection diabetes retinal scan process over 90% accurate with potential to prevent blindness.
     

     

    GLYTHERIX

    Developers of Miltuximab- binds to unique cancer protein marker Glypicam-1(“GPC-1”), enabling a cytotoxic payload delivery direct to tumor, destroys only the cancer cell

     

    MINOMIC

    Executive Summaries

    for accredited investors only:

    Victoria@steelwolfventures.com

     

    JANGO BIO 20M

    Executive Summaries

    for accredited investors only:

    Victoria@steelwolfventures.com

     

    SWEEGEN 80M

    Executive Summaries

    for accredited investors only:

    Victoria@steelwolfventures.com

     

  • PROJECTS

    Q - 4 / 2021

    executive summaries available for accredited investors only

    BAREMA 3M

    Customized luxury tiny house with a post modern design- wood, steel and reflective glass units are connectable for expansion of square footage and adaptable shapes/sizes. Made in USA

     

    PARA NETICS

    A next gen type of EV motor driven by an ancillary power source moving a engine designed to create maximum efficiency

     

    SYMSOIL JV

     
    Spoke locations to develop or JV to produce compost comprised of  microbes blended as probiotic for plant nutrition; alternative to agri-chemical fertilizers. 

    R E SO CAL 210

    Residential Mini-Units

    Mini luxe apartments (average 350 sq ft) Central location walk to beach and Metra. Development deal partnership with private equity and 10 yrs of tax incentives

    SANTA BARBARA

    Development project; old winery, partially completed multi-story French chateau style building to convert into wellness center, B&B or potential luxe retreat. Airplane landing strip, on site wells, power

    OMNIPAD

    Omnidirectional running track; A prototype in development SFO.
    Expect the Oculus VR to take you anywhere you virtually choose

    PECAN TV 2M

    Short burst video content, animation

    comedy / drama / reality promoting upcoming underrepresented artists

    to be placed with digital media / 

     

    IRON ORE

    Existing MINE West Australia
    In Production = sales / expansion 
     

    Executive Summary to

    accredited investors only

    Victoria@steelwolfventures.com

    UXV - (Info- entertainment)

     

    Executive Summary to

    accredited investors only

    Victoria@steelwolfventures.com

    coming Q- 1 2022

    *  modular home fsctories
     
    * 5G tower AI / Drone support
     
     
     
  • Connect With Us

    Accredited Investors and Entrepreneurs

    Learn more about collaboration & opportunities

     

    Team : R Victoria Jodis / Mark Dirkse / Peter Newton John / Jonathan Whitcomb Esq.

    Board: Robert Moore Esq. Public Affairs: Jill Shestokas

    Affiliates: Erik Brown, Robert Gray, Jeremy Edelstein, Greg McCloskey

     

    Steel Wolf - a boutique consulting company that finds, markets, researches, 
    collaborates with and invests in new cutting-edge 1B +business

     

    STEEL WOLF VENTURES
    489 South Robertson Blvd.
    Beverly Hills, California 90211
    Newport Beach California (virtual)
    Palo Alto California (virtual)
    Chicago (virtual)
    Boca Raton, Florida (virtual)
    Manhattan (Virtual)
    BH 310 855 2282
  • Media

    STEEL WOLF VENTURES

    Press

     
    STEEL WOLF VENTURES PIERCING BILLION DOLLAR MARKETS 
    BEVERLY HILLS, CA – November 19, 2021 
     
    Steel Wolf Ventures (SWV) today announced more than $250M in active projects with a market potential of 1B+ each. This record-breaking year for growth equity, has buoyed SWV's entrepreneurs, young high-growth companies, ESG, AI and SaaS, as well as breakthrough health and medical businesses to secure immediate as well as on-going funding. 
     
    Business leader and SWV founder, R. Victoria Jodis said her elite boutique venture firm accelerates their clients’ access to the right money for post seed/pre-IPO businesses and inventors. “We keenly focus on our client’s long-term development and excel in delivering world class results.  
     
    “Our team includes stellar investment banker, Peter Newton John, corporate attorney Robert Moore, and Principal Mark Dirkse. Each has distinguished records- from consummating billion dollar deals globally to negotiating through both entrepreneurial and corporate stages.  
     
    "We leverage our experience, abilities, and relationships as strategic partners developing and accelerating early-stage businesses. Founders can focus on their cutting-edge products and growing revenue,” she said.  
     
    SWV’s revolutionary projects are in ag-tech, biotech, Medtech, SaaS, AI, comms, health, lifestyle, manufacturing, and real estate development. Appreciating ESG culture, SWV unpacks prosperity with social integrity and NetZero mandates. “Investors in this ecosystem can prosper and exponentially create American jobs with a socially responsible and pro-business approach while supporting both pro-environment choices and promoting human rights,” Jodis concluded. 
     
    CONTACT: Jill B. Shestokas i
    nfo@swventures.net  312 330 7447 
     
     
    XXX
     
     

     

    STEEL WOLF VENTURES REDEFINES TRADITIONAL CAPITAL RAISES

    Seasoned Investor Group Niche Building

    Beverly Hills, CA, July 22, 2019 - Newly formed Steel Wolf Ventures (SWV) has announced a hybrid business investment and equity funding model for cutting edge entities beyond family and friends financing in capitalization needs but yet not large enough for traditional institutional funding.

     

    Recognizing a void in fundraising options for emerging companies, SWV partners strategically researches innovative ventures in potential $1B+ plus markets, poised to thrive with the right investment or financing Their choice is to foster and raise impact investments in five sectors - bio, tech, health & medical (including CBD/cannabis), clean energy and RE/development.

     

    Partner and Founder, R. Victoria Jodis, a California entrepreneur, has significant inside experience with business and media. Jodis said, “the partners found worthy companies that consistently fell into a ‘financial black hole.’ Investment Bankers are beyond their reach and small/ineffective crowdfunding sites either can’t deliver enough money or are not fast enough.”

     

    “Emerging and startup companies needing $1 to $5 million and up to $50- 100 million in capital are quite different than large established corporations with EBITDA seeking capital, development or M&A financing. They can’t grow their businesses without private equity and other investment opportunities” Jodis continued. “Entrepreneurs have varying degrees of business savvy. To be without a clear development timetable, market strategy, product integrity, a detailed budget and plan to profitability or a potential exit strategy is business suicide. Over all though, they all have the very same single issue – money,” Jodis concluded.

     

    Fellow affiliates and partners say “Steel Wolf provides an effective and efficient way for small emerging firms to compete for capital needed to make their companies viable entities.”

    As a team - we can help scale- and are stronger.

     

    Steel Wolf’s hybrid business model discards Investment Bank/Wall Street structure. Modest upfront fees include expenses, team evaluation and strategic development. SWV takes some ownership, provides engagement with the client-founder as new board members and partners while marketing and developing accredited investor streams or other private equity sources, and potential new channels so the founder fully focuses on product, markets and revenue.

     

    SWV raises for Q3 2019 include these companies with double digit, high growth and sustainable $1B+ market potential:

    • SymSoil ®, $5M initial raise - going to $45M+ Organic/bio-fertilizer/microbe soils technology with water conservation properties increases yields 15 to 35%; Projected markets revenues $2B+

     

    • OmniPad, $5M initial raise - going to Series A $40M VR tech merged with patented omnidirectional treadmill equipment and high-speed running platform. Final development funds prior to manufacture. Several verticals including sports, gaming, medical rehab/physical therapy and military/first responder applications. Projected markets revenues $1B+

     

    Accredited Investors / Entities / Entrepreneurs :
    310 855 2282 / Beverly Hills &
    Newport Beach

     

     

    ###

    For more Information: Marketing@SteelWolfVentures.com

     

    F O N / April

     

     

    For investors who want to act rather than stand still, execution of acquisitions and sales has been hampered by market volatility and illiquidity. Many deals have been extended or canceled altogether due to the inability to wrap up previously approved financing. The banks are overwhelmed, making traditional financing hard to execute despite low-interest rates.

    During this virus crisis, some businesses may need an investor lifeline while a small percentage- are doing very well right now and growing faster than they can keep up with. In either case, an investor connection is a must-have tool to accelerate outreach. Here are many of the opportunities Family Office Investors are currently seeking:

    1. Distressed Opportunities: Assets & companies which had good profits and revenue before the virus crisis but now need a cash infusion or investment to make it through this period.
    2. Growth Opportunities: Healthcare, medical supply, medical equipment, decontamination services, supply chain services, or subscription/recurring revenue services related to these areas.
    3. Subscription Offerings: Recurring revenue and subscription service companies that have not been damaged by the virus.

     

  • Newsmakers

    VENTURE - REPORT. COM celebrities dealmakers investments markets projects researchers ventures

    MARCH 2020

    The Case for Private Markets

    excerpts - by Jason Frishman

     

    Recent stock market declines in response to the uncertainty arising from the spread of the novel Covid-19 Coronavirus have caused many investors to reassess their portfolios. Stocks have been sold at the fastest rate since the financial crisis of 2007-2008. Investors seeking the relative safety of U.S. Treasury bonds have bid their prices up, driving down yields to historic lows.

     

    In such uncertain times, where risks abound in any investment opportunity, investors should consider allocating capital to invest in the private markets. If you are taking risk investing in public or private equities, you should consider taking the risk which comes with the possibility of an outsized return. Those wild price gyrations of the public markets -- down several points one day, back up another, only to plummet again the next -- really unnerve most investors. And when the declines get as bad as they have recently, many investors throw in the towel and sell, fearful that more pain is ahead.

     

    Publicly traded stocks face a double whammy when a market disruption occurs, such as the Covid-19 outbreak. As forecasters begin to talk about a looming recession, investors anticipate declining earnings, and are no longer willing to pay a lofty multiple for those earnings. When multiples contract, a stock whose earnings decline by X may see its price decline by 2X, or 3X, or even more.

     

    Not so in the private markets. Entrepreneurs looking to raise capital for their private businesses offer investors shares in a portion of the company that reflect its value at that time. Investors are attracted by the opportunity to get in early and hold shares in the hope of a future reward -if the company goes public or gets bought out at a premium. Shares are not traded publicly so they are not subject to the volatility that comes from waves of investor panic and pessimism when broad market conditions deteriorate. It’s the ultimate buy and hold strategy, which many veteran investors say is the best way to build wealth over the long term.

     

    The mainstream media and Wall Street analysts would have investors believe that public stocks are far safer than private stocks. But recessions like Covid-19 and scandals like Enron continue to prove the truth: there is risk everywhere. Some investors choose an asset which offers outsized returns like private market stocks, where one’s money can make a difference in the company being invested in, and create real value in the world.

     

    For many years, opportunities to invest in private companies were restricted to accredited (high net worth) investors and largely controlled by venture capitalists and private equity firms. But this all changed with a new regulation under Section 4(a)(6) (Reg CF) of the JOBS Act, which allows investors of any means to invest in private companies. Under this regulation, private companies offer their securities in various formats - events, online, or pitch panels - which enables these investors to participate

     

    Owning securities that are not publicly traded comes with a small cost – a lack of liquidity. This can be a dual-edged sword. Investors like to know they can have access to their funds, but they can also have a tendency to sell stock at inopportune times during market panics. Nonetheless, personal circumstances can change over time and make illiquidity a problem for an investor. While early stage private companies may be immune from the risk associated with trading volatility, they are a riskier proposition than larger, more established companies. Not all startups will succeed. So as one dives into the world of private investing, it makes sense to keep some basic principles in mind.

     

    Number one: diversify. Investing in multiple offerings decreases your specific risk in any one investment.

     

    Number two: assess your tolerance for risk. Don’t allocate more to higher risk investments than you can afford to lose.

     

    Number three: think long term. Investing in early stage companies creates the opportunity to participate in significant growth, but investors should expect it may take several years or more for such an investment to pay off.

    Keeping those principles in mind, there is no reason an investor should not consider private market investing as part of a broadly diversified portfolio.

     

     

  • LUMOPTIK

    Victoria interviews

    Dr Stephen Banko:

     

    Interview with

    Dr Stephen Banko, Orthopedic surgeon and also an investor raising for the next runway

    LUMOPTIK

    Brightpoint Technology 2021